Skip to main content

Advertisement

Table 3 Lifetime costs, outcomes, and ICERs of alternative treatment options

From: Cost-utility analysis of adjuvant imatinib treatment in patients with high risk of recurrence after gastrointestinal stromal tumour (GIST) resection in Thailand

Treatment options Cost (THB) Life years QALYs ICER (THB per QALY gained)
No discount Discount
Option 1 (current practice) 2,744,275 8.13 6.72 5.34
Option 4 3,368,809 8.57 7.05 5.58 Dominated by option 2.2
Option 2.1 3,393,388 8.56 7.01 5.63 Dominated by option 2.2
Option 3.1 3,979,869 8.97 7.33 5.86 Dominated by option 2.2
Option 2.2 4,648,080 9.87 7.95 6.50 1,648,801
Option 3.2 5,056,583 10.17 8.17 6.65 2,608,264